Condition
Cell-free DNA
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting2
Unknown1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07006831Recruiting
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
NCT07060716Recruiting
Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
NCT06537063Withdrawn
Detection of G-quadruplex DNA Methylation in Cancer
NCT04651946Phase 2Unknown
Cell-free DNA Methylation for Epithelial Ovarian Cancer
Showing all 4 trials